Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (27)
  • Speech (21)
  • Announcements (3)
  • In the News (1)
  • Publication (141)

Publication Type

  • Intelligence (70)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (22)
  • Forensics (10)
  • DEA Administrator (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (15)
  • Heroin (7)
  • Methamphetamine (6)
  • Cannabis (4)
  • Drugs of Concern (4)
  • Marijuana (4)
  • Xylazine (3)
  • Cocaine (2)
  • Fentanyl (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)
  • Synthetic Opioids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
DOCUMENT

Joint Intrepid Laboratory Releases Priority Project: Sourcing Xylazine

Octubre 19, 2023
Publication
INTREPID confirms both liquid veterinary preparations and powdered xylazine are being used to adulterate fentanyl. INTREPID observed chemical markers in xylazine seizures that can assist in determining precursors, synthetic routes, and potentially connecting cases.
Octubre 19, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Cannabis Plant Material

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 1, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Cocaine

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 2, 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Methamphetamine

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is January 25, 2023 to November 5, 2023 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Cannabis Liquids and Extracts

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 15, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Natural and Synthetic Opioids

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of February 1 , 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in...
Agosto 02, 2023
DOCUMENT

DEA Foreign Review Report

Marzo 24, 2023
Publication
The Drug Enforcement Administration received the "Report on the Drug Enforcement Administration Foreign Operations Review," which contains findings and recommendations to assess our foreign operations, enhance our integrity efforts, and maximize the impact of our global work. DEA requested the comprehensive review in August 2021 to evaluate the strengths and...
Marzo 24, 2023
DOCUMENT

The Growing Threat of Xylazine and its Mixture with Illicit Drugs

Diciembre 21, 2022
Publication
Xylazine, reported as an adulterant in an increasing number of illicit drug mixtures, has also been detected in a growing number of overdose deaths. It is commonly encountered in combination with fentanyl but has also been detected in mixtures containing cocaine, heroin, and a variety of other drugs. However, xylazine...
Diciembre 21, 2022
DOCUMENT

Complexities and Conveniences in the International Drug Trade

Diciembre 14, 2022
Publication
This report delves into the activities of these criminals and their methods. Drug trafficking operations benefit from a number of different actors, such as brokers, cooks, envoys, intermediaries, and money laundering service providers. Examples of the methods used by the criminals include the corruption of officials in the public and...
Diciembre 14, 2022
DOCUMENT

Summary of Validated Qualitative Methods

Diciembre 07, 2022
Publication
This document is an internal Drug Enforcement Administration quality system document which provides a summary of validated quantitative and qualitative methods. The document is updated periodically and current as of December 7th, 2022, and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted...
Diciembre 07, 2022
Showing 31 - 40 of 141 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 3
  • Current page 4
  • Página 5
  • Página 6
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster